Ipswich, MA, United States of America

Tien-Hao Chen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: New England Biolabs, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tien-Hao Chen: Innovator in In Vitro Transcription

Introduction

Tien-Hao Chen is an accomplished inventor based in Ipswich, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of in vitro transcription. His work has led to the development of innovative solutions that enhance research capabilities in molecular biology.

Latest Patents

Tien-Hao Chen holds a patent titled "Compositions, Kits, and Methods for In Vitro Transcription." This patent represents his commitment to advancing scientific knowledge and providing tools that facilitate research in various biological applications. He has 1 patent to his name, showcasing his innovative contributions to the field.

Career Highlights

Chen is currently employed at New England Biolabs, Inc., a leading company in the life sciences sector. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research and product development. His work is instrumental in driving forward the capabilities of in vitro transcription technologies.

Collaborations

Throughout his career, Tien-Hao Chen has worked alongside talented colleagues, including Jennifer L. Curcuru and Lili Mitchell. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Tien-Hao Chen is a notable inventor whose work in in vitro transcription has made a significant impact in the field of biotechnology. His contributions continue to support advancements in molecular biology research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…